Abstract
The RET proto-oncogene encodes a receptor tyrosine kinase expressed during neural crest development. RET expression is enhanced in vitro by several differentiating agents, including retinoic acid (RA), which up-regulates RET expression in neuroblastoma cell lines. In the present work we sequenced and analysed a 5 kbp genomic fragment 5' to RET. Three deletion fragments of this region were tested for their RA inducibility in transient transfection assays and failed to support the hypothesis of a direct transcriptional activation. Finally, our functional analysis of a candidate RA response element present in the RET promoter provides new hints for the understanding of the interaction between nuclear receptors and their specific recognition sites.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Base Sequence
-
Drosophila Proteins*
-
Gene Expression Regulation / drug effects*
-
Gene Expression Regulation / genetics
-
HeLa Cells
-
Humans
-
Molecular Sequence Data
-
Neuroblastoma
-
Promoter Regions, Genetic / genetics
-
Proto-Oncogene Mas
-
Proto-Oncogene Proteins / genetics*
-
Proto-Oncogene Proteins c-ret
-
Proto-Oncogenes / genetics*
-
RNA, Messenger / analysis
-
Receptor Protein-Tyrosine Kinases / genetics*
-
Recombinant Fusion Proteins
-
Regulatory Sequences, Nucleic Acid / genetics*
-
Restriction Mapping
-
Sequence Analysis, DNA
-
Transcription, Genetic / drug effects
-
Transcription, Genetic / genetics
-
Transfection
-
Tretinoin / pharmacology*
-
Tumor Cells, Cultured
Substances
-
Drosophila Proteins
-
MAS1 protein, human
-
Proto-Oncogene Mas
-
Proto-Oncogene Proteins
-
RNA, Messenger
-
Recombinant Fusion Proteins
-
Tretinoin
-
Proto-Oncogene Proteins c-ret
-
Receptor Protein-Tyrosine Kinases
-
Ret protein, Drosophila